This is a notice of intent for a sole-source, one-year contract to provide HLA typing and antibody screening reagents to the HLA Lab at the NIH Clinical Center in Bethesda, MD. The reagents will be shipped on an “as needed/requested” basis, typically within one week of ordering. The intended vendor, One Lambda Inc., is the sole manufacturer of these specific reagents, which are already validated and used by the lab. No budget amount is specified. The government will accept comments on this notice until May 27, 2026, at 10 am EST.